2024/08/16 15:50:59 | |
---|---|
Price | |
0.572 USD | |
Difference | -2.26% (-0.01) |
ISIN | US90137F3010 |
Symbol | XXII |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 0.562 USD (200) |
Ask (Ask size) | 0.572 USD (500) |
Open | 0.58 USD |
High | 0.5999 USD |
Low | 0.562 USD |
Close (prev. day) | 0.5852 USD |
VWAP | 0.577582 USD |
Volume (pcs) | 38,478 |
Trading volume | 22,235.29 |
Number of trades | 120 |
Last size | 300 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings |
2024/08/16 15:50:59 | |
---|---|
Price | |
0.572 USD | |
Difference | -2.26% (-0.01) |
ISIN | US90137F3010 |
Symbol | XXII |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 5 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 0.562 USD (200) |
Ask (Ask size) | 0.572 USD (500) |
Open | 0.58 USD |
High | 0.5999 USD |
Low | 0.562 USD |
Close (prev. day) | 0.5852 USD |
VWAP | 0.577582 USD |
Volume (pcs) | 38,478 |
Trading volume | 22,235.29 |
Number of trades | 120 |
Last size | 300 |
6m | 1Y | 3Y | |
Perf (%) | -76.70% | -98.21% | -99.09% |
Perf (abs.) | -1.93 | -32.05 | -63.89 |
Beta | 1.42 | 1.40 | 1.49 |
Volatility | 176.19 | 147.86 | 189.04 |
Ø price 5 days | Ø volume 5 days (pcs.) | 0.660 USD (237,890) |
Ø price 30 days | Ø volume 30 days (pcs.) | 0.724 USD (163,687) |
Ø price 100 days | Ø volume 100 days (pcs.) | 1.175 USD (1,152,842) |
Ø price 250 days | Ø volume 250 days (pcs.) | 5.328 USD (501,131) |
YTD High | date | 4.310 USD (2024/04/05) |
YTD Low | date | 0.580 USD (2024/06/24) |
52 Weeks High | date | 35.198 USD (2023/08/22) |
52 Weeks Low | date | 0.580 USD (2024/06/24) |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer